Navigation Links
EntreMed Receives Notice of NASDAQ Compliance
Date:10/15/2010

statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time.  Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed. Actual results could differ materially from those currently anticipated due to a number of factors, including those set forth in Securities and Exchange Commission filings under "Risk Factors," including  the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility of our common stock; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; the failure to consummate a transaction to monetize the royalty stream for any reason, including our inability to obtain the required third-party consents; declines in actual sales of Thalomid® resulting in reduced revenues; risks associated with the Company's product candidates; the early-stage products under development; results in preclinical models are not necessarily indicative of clinical results; uncertainties relating to preclinical and clinical trials, including delays to the commencement of such trials; success in the clinical development of any products; dependence on third parties; future capital needs; and risks relating to the commercialization, if any, of the Company's proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).  Contact:Ginny DunnAssociate DirectorCorporate Communications & Investor Relations240-864-2643
'/>"/>
SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
2. EntreMed Raises $20 Million to Support Clinical Development Program
3. EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
6. EntreMed to Present at The New York Society of Security Analysts Industry Conference
7. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
8. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
9. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
10. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
11. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 21, 2014 Clementia Pharmaceuticals, ... Agency (EMA) has granted Orphan Medicinal Product ... candidate, for the treatment of fibrodysplasia ossificans ... disabling genetic disease characterized by painful, recurrent ... new abnormal bone formation. This process, known ...
(Date:11/21/2014)... 2014  Edwards Lifesciences Corporation (NYSE: EW ... valves and hemodynamic monitoring, announced today that it will ... a strong launch of Edwards Lifesciences Foundation,s new charitable ... the global communities where its employees live and work. ... will exceed $8 million, including more than $7 million ...
(Date:11/21/2014)... MEDICAL CORP. (NYSE: CMN ) announced today that ... presenting at the 26 th Annual Piper Jaffray Healthcare ... New York . The formal presentation is scheduled for ... Mr. Krakauer and Jorgen B. Hansen , President and ... day. An audio webcast will be available ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2
... CLARA, Calif., March 7, 2011 Samplify Systems, Inc., ... medical, industrial, wireless, and scientific markets, has completed its ... enables the company to fund its rapid growth in ... new markets.  Participating in the round are Integrated Device ...
... plc (Nasdaq: WCRX ) today announced that its ... scheduled to speak at the Goldman Sachs Leveraged Finance Healthcare ... The presentation will be simultaneously webcast at ... available shortly thereafter at http://ir.wcrx.com/events.cfm . ...
Cached Medicine Technology:Samplify Systems Completes Series B Funding 2Samplify Systems Completes Series B Funding 3
(Date:11/23/2014)... thanks to new and old customers, iFitDress.com has recently ... for weddings. Customers who need custom outfits can talk to ... manufacturer, and it is among the ones which have been ... time. The CEO of this company says, "iFitDress.com is a ... not only a beautiful dress, but also a piece of ...
(Date:11/23/2014)... Asher Milgrom, is a celebrity ... was recently featured on International Business Times. ... CEO of American Medical Aesthetics & Wellness, also known ... full scholarship to attend an M.D./Ph.D program at University ... University of Chicago, where his field of study was ...
(Date:11/23/2014)... 23, 2014 Wright & Schulte LLC ... Ohio and West Virginia residents who allege that they ... disorders due to drinking C8 contaminated water released ... Virginia. According to the C8 complaints, the plaintiffs were ... or lived in at least one of the six ...
(Date:11/22/2014)... A new AlignLife Chiropractic & Natural Health ... Greenville area. Dr. Chelsea Sineath, owner and chiropractor at ... her own clinic after working in another AlignLife office ... , AlignLife believes that the body can heal itself ... chiropractic care and rehabilitation to allow the spine to ...
(Date:11/22/2014)... November 23, 2014 A classic black prom ... the most famous dress suppliers, has unveiled its new items ... dresses are now offered at a big discount, up to ... offer. , The new black prom dresses, made with ... to meet the needs of all customers, the company provides ...
Breaking Medicine News(10 mins):Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 2Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 3Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 4Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:New Black Prom Dresses from BellasDress.com 2
... SEATTLE, July 2 The Washington State Medical,Association ... in Washington state. The opposition was,emphatically voted on ... "We believe physician-assisted suicide is fundamentally incompatible,with the ... Brian P.,Wicks, MD. "Patients put their trust in ...
... July 2 VNUS(R) Medical,Technologies, Inc. (Nasdaq: ... the minimally invasive treatment of venous reflux disease, ... in the United States,District Court, Northern District of ... (Dornier) and NewStar Lasers,Inc. d/b/a CoolTouch, Inc. (CoolTouch)., ...
... study in the Journal of,the American Veterinary Medical Association ... World Trade Center after the terrorist,attacks of September 11, ... study focuses on 27 dogs that assisted in relief ... the 37-week cleanup,operation. Both short-term and long-term health assessments ...
... a Dolphin in your bed?, Dolphin-shaped condom ushers in The ... ... 2 Intellx Inc. introduces the,SafeSexyShapes(TM) line of designer-condoms. Remarkably ... ... think phallic and/or fun. What condom designers could only ...
... Annual Fundraiser Brought Together Celebrities, Community,Leaders to Support ... LOS ANGELES, July 2 Performances by ... highlights of Trevor,New York, the eighth annual New ... organization that operates the only nationwide,around-the-clock crisis and ...
... PARK, Ill., July 2 Jewel-Osco, a leading,Midwest food ... the,sale of 1 million green reusable shopping bags, reflecting ... more and more people buying and using recyclable,shopping bags," ... to the heightened awareness about the environment and the ...
Cached Medicine News:Health News:As I-1000 Signatures are Counted, Washington State Medical Association Opposition to Physician-Assisted Suicide Reiterated 2Health News:VNUS Medical Technologies, Inc. Files Patent Infringement Lawsuits Against Biolitec, Dornier and CoolTouch 2Health News:Study: 9/11 Dogs Suffered Few Health Effects 2Health News:The New Condom That Breaks - - - the Mold. 2Health News:The Trevor Project Raises Lifesaving Proceeds, Awareness at Trevor New York Benefit 2Health News:Jewel-Osco: 1 Million Reusable Shopping Bags Sold 2
Rapid Test Kit...
... (Nidek Advanced Vision Information System) is an ... software on a platform designed to communicate ... The network can be expanded in various ... to Nidek products but also to fundus ...
... OcuLight family of infrared laser photocoagulators includes ... These diode lasers serve as a single ... applications, require no regular maintenance or special ... compact design. The OcuLight SLx is now ...
The simplest, most accurate Ortho-K lens fitting system ever!...
Medicine Products: